Yahoo Web Search

  1. NASDAQ: BLUE) Corvus Pharmaceuticals Inc (NASDAQ: CRVS) DelMar Pharmaceuticals Inc (NASDAQ: DMP) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) Erytech Pharma ...

  2. The following is a roundup of top developments in the biotech space over the last 24 hours. Biotech stocks that hit 52-week highs Sept. AstraZeneca plc (NYSE: AZN) GlaxoSmithKline plc (NYSE: ...

  3. NASDAQ: GILD) Type of Application: sNDA Candidate: Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets) Indication: Pre-exposure prophylaxis, or PrEP, for HIV-1 infection Date ...

  4. Coherus Biosciences Inc (NASDAQ: CHRS) The Medicines Company (NASDAQ: MDCO) (Biotech stocks that hit 52-week lows Sept.

  5. Theravance's (TBPH) newly-launched COPD drug Yupelri is witnessing a solid adoption while its pipeline programs are also progressing well. However, excessive reliance on Yupelri for revenues is a woe.

  6. The Medicines Company (NASDAQ: MDCO) Ra Pharmaceuticals Inc (NASDAQ: RARX) (announced a deal to be bought by Belgium's UCB) (Biotech stocks that hit 52-week lows Oct. 10.

  7. NASDAQ: AMGN)'s Forteo, and Australian biotech Clinuvel Pharmaceuticals Ltd (OTC: CLVLY)'s Scenesse to treat erythropoietic protoporphyria was also given the go-ahead by the regulatory ...

  8. J&J Unit Ordered to Pay $8 Billion Over Anti-Psychotic Drug

    Bloomberg via Yahoo FinanceOct 09 11:27 AM

    A state court jury in Philadelphia Tuesday concluded the Janssen’s wrongful marketing of its Risperdal drug to teens warranted the punishment award in the first Pennsylvania case in which ...